165 related articles for article (PubMed ID: 23534242)
1. [Connective tissue diseases: news in therapy, role of biologics agents].
Aubry-Rozier B; Fabreguet I
Rev Med Suisse; 2013 Mar; 9(377):556, 558-60. PubMed ID: 23534242
[TBL] [Abstract][Full Text] [Related]
2. Sjögren syndrome and systemic lupus erythematosus are distinct conditions.
Scheinfeld N
Dermatol Online J; 2006 Jan; 12(1):4. PubMed ID: 16638372
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of connective tissue disease.
Ciavaglia SJ; Costello PB; Panara N
Ear Nose Throat J; 1987 Nov; 66(11):457-62. PubMed ID: 3443075
[No Abstract] [Full Text] [Related]
4. [Recent advances in diagnosis and treatment of connective tissue diseases].
Lorenz HM
Dtsch Med Wochenschr; 2011 Apr; 136(14):710-2. PubMed ID: 21448833
[No Abstract] [Full Text] [Related]
5. Rituximab and lupus interstitial lung disease: friend or foe?
Efthimiou P; Kukar M; Hersh A
Int J Rheum Dis; 2011 Feb; 14(1):e3-4. PubMed ID: 21303472
[No Abstract] [Full Text] [Related]
6. [Treatment of connective tissue diseases with biological agents].
So A
Rev Med Suisse; 2008 Mar; 4(149):707-8, 710. PubMed ID: 18472731
[TBL] [Abstract][Full Text] [Related]
7. Hydroxycholoroquine-induced hyperpigmentation.
Mir A; Boyd KP; Meehan SA; McLellan B
Dermatol Online J; 2013 Dec; 19(12):20723. PubMed ID: 24365014
[TBL] [Abstract][Full Text] [Related]
8. B-cell depletion and repopulation in autoimmune diseases.
Pers JO; Daridon C; Bendaoud B; Devauchelle V; Berthou C; Saraux A; Youinou P
Clin Rev Allergy Immunol; 2008 Feb; 34(1):50-5. PubMed ID: 18270858
[TBL] [Abstract][Full Text] [Related]
9. The association of myasthenia gravis and connective tissue diseases--the role of Sjøgren's syndrome.
Yasuda M; Nobunaga M
Fukuoka Igaku Zasshi; 1994 Feb; 85(2):38-51. PubMed ID: 8144128
[TBL] [Abstract][Full Text] [Related]
10. Emerging therapeutics in the management of connective tissue disease. Part I. Lupus erythematosus and Sjögren syndrome.
Skudalski L; Shahriari N; Torre K; Santiago S; Bibb L; Kodomudi V; Grant-Kels JM; Lu J
J Am Acad Dermatol; 2022 Jul; 87(1):1-18. PubMed ID: 35202775
[TBL] [Abstract][Full Text] [Related]
11. Progress and regression within primary Sjögren's syndrome.
Manthorpe R; Bredberg A; Henriksson G; Larsson A
Scand J Rheumatol; 2006; 35(1):1-6. PubMed ID: 16467033
[TBL] [Abstract][Full Text] [Related]
12. Will targeting B cells be the answer for Sjögren's syndrome?
Looney RJ
Arthritis Rheum; 2007 May; 56(5):1371-7. PubMed ID: 17469093
[No Abstract] [Full Text] [Related]
13. Musculoskeletal Manifestations of Non-RA Connective Tissue Diseases: Scleroderma, Systemic Lupus Erythematosus, Still's Disease, Dermatomyositis/Polymyositis, Sjögren's Syndrome, and Mixed Connective Tissue Disease.
Jacques T; Sudoł-Szopińska I; Larkman N; O'Connor P; Cotten A
Semin Musculoskelet Radiol; 2018 Apr; 22(2):166-179. PubMed ID: 29672805
[TBL] [Abstract][Full Text] [Related]
14. The connective tissue diseases and the overall influence of gender.
Lahita RG
Int J Fertil Menopausal Stud; 1996; 41(2):156-65. PubMed ID: 8829695
[TBL] [Abstract][Full Text] [Related]
15. Quantification and molecular characterization of regulatory T cells in connective tissue diseases.
Banica L; Besliu A; Pistol G; Stavaru C; Ionescu R; Forsea AM; Tanaseanu C; Dumitrache S; Otelea D; Tamsulea I; Tanaseanu S; Chitonu C; Paraschiv S; Balteanu M; Stefanescu M; Matache C
Autoimmunity; 2009 Jan; 42(1):41-9. PubMed ID: 18800250
[TBL] [Abstract][Full Text] [Related]
16. Use of B lymphocyte stimulator inhibitor belimumab may be associated with a decrease in the serum concentration of epidermal growth factor in patients with primary Sjögren's syndrome.
Kadavath S; Bobic S; Efthimiou P
Clin Rheumatol; 2015 Sep; 34(9):1651-2. PubMed ID: 25652332
[TBL] [Abstract][Full Text] [Related]
17. The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome.
Saraux A
Autoimmun Rev; 2010 Jul; 9(9):609-14. PubMed ID: 20452466
[TBL] [Abstract][Full Text] [Related]
18. Neurologic manifestations of connective tissue disease.
Nadeau SE
Neurol Clin; 2002 Feb; 20(1):151-78, vi. PubMed ID: 11754305
[TBL] [Abstract][Full Text] [Related]
19. Rituximab therapy in primary Sjögren's syndrome.
Alcântara C; Gomes MJ; Ferreira C
Ann N Y Acad Sci; 2009 Sep; 1173():701-5. PubMed ID: 19758218
[TBL] [Abstract][Full Text] [Related]
20. T cells and the loss of immunologic tolerance in Sjögren's syndrome and systemic lupus erythematosus.
Hoffman RW
Arthritis Rheum; 2007 Oct; 56(10):3180-2. PubMed ID: 17907162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
